Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.
about
Histoplasmosis: a clinical and laboratory updateJoint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working groupComparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS.Antifungal clinical trials and guidelines: what we know and do not knowManagement of histoplasmosis.Challenges in the management of disseminated progressive histoplasmosis in human immunodeficiency virus-infected patients in resource-limited settings.Quantitative Microplate-Based Growth Assay for Determination of Antifungal Susceptibility of Histoplasma capsulatum Yeasts.Detection of histoplasma antigen by a quantitative enzyme immunoassayHistoplasmosis: a review for clinicians from non-endemic areas.Detection of Histoplasma capsulatum antigen in Panamanian patients with disseminated histoplasmosis and AIDSImprovements in diagnosis of histoplasmosis.Clinical pharmacology of antifungal agents in pediatric patients.Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review.Clinical Characteristics, Diagnosis, Management, and Outcomes of Disseminated Emmonsiosis: A Retrospective Case Series.Comparison of an established antibody sandwich method with an inhibition method of Histoplasma capsulatum antigen detection.Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.Histoplasmosis in transplant recipients.Antigen assay with the potential to aid in diagnosis of blastomycosis.Cutaneous and bone marrow histoplasmosis after 18 years of renal allograft transplant.Histoplasmosis in HIV-Infected Patients: A Review of New Developments and Remaining Gaps.Evaluation of reagents for detection of Histoplasma capsulatum antigenuria.Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors.New agents for the treatment of systemic fungal infections--current status.Diagnosing Ring-Enhancing Lesions in the Brain of a Patient With AIDS Without Brain Biopsy: A Case of Central Nervous System Histoplasmoma.Reduced susceptibility to fluconazole in a cat with histoplasmosis.A case of emmonsiosis in an HIV-infected child.Factors Associated with Severe Manifestations of Histoplasmosis in AIDS
P2860
Q24675642-AA436C26-9BAE-4412-BFD4-26560DC1E0C8Q30779044-9434ECD9-DB76-4773-9E80-E77703039726Q33976048-ECC18EBC-3910-4146-BFD2-C9357853CAC4Q34104766-60BC8141-9DFA-4861-9365-AF8C4408A718Q34400255-E2811DE1-F821-4E19-82EA-2BDEA31CB76CQ34768480-AC1F1E7C-DBFE-45A2-8F60-55739480E4E4Q35628309-5CC307A7-3198-4B6F-B602-8E932CCA63A1Q36066802-652CE536-1650-4204-B31D-F2FEC008CF66Q36314106-F7418FDD-8AEA-45DF-ACA2-56C601887305Q36511359-D53B7367-2F02-4FE1-9FC3-53CDDF5DCA08Q36539031-C5369859-1EC2-4891-8E29-66D772419F31Q36627264-5982E091-F850-4F71-B698-D76FDEE087B7Q36968140-1E642A4B-8BB3-4249-9D1C-3D57FEAB4880Q37164085-E2301B85-87C9-4860-AD64-6DF23925103DQ38195802-EC5D22A8-6B92-430B-B8F8-991B06E75D43Q38523245-3FB23A08-EF31-4FB1-A1FE-6CB970AE7AE1Q39459980-08005EE4-9A3C-4784-AEE1-2713D3FFEBC2Q39475167-B16E0B0D-E259-480D-A904-CD5F20BDE19FQ40043530-424E1659-90C1-4FE8-B6EA-B14CFD8D6941Q40180385-5E2CF69B-579B-43BA-AE30-842918BABB8AQ40197921-790A91B4-9439-446C-AF35-EF8363B11223Q42584304-49A6B850-8ED0-4A45-A597-1693995D148EQ42909263-57F5599D-0178-41F4-B7DA-FE71BB277737Q43787814-87718922-786E-4562-B2CD-11DF8B433C10Q44696147-D4D2CC64-61C4-4D36-BB58-F8AC40271705Q46576615-9F60A3FA-C7E1-4F81-8491-E941FB4F3E1DQ52603575-A9C86EC3-C1EE-4C46-AB74-2204CC381907Q52756298-43E32C16-4F86-4239-82DF-1D7C70151D5EQ55229511-D1A32230-F883-4A22-82F4-FED424197942Q59230857-DB7BAF27-FDA9-401A-B3B9-127919D3B0E2
P2860
Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Treatment of histoplasmosis wi ...... Group and Mycoses Study Group.
@en
Treatment of histoplasmosis wi ...... Group and Mycoses Study Group.
@nl
type
label
Treatment of histoplasmosis wi ...... Group and Mycoses Study Group.
@en
Treatment of histoplasmosis wi ...... Group and Mycoses Study Group.
@nl
prefLabel
Treatment of histoplasmosis wi ...... Group and Mycoses Study Group.
@en
Treatment of histoplasmosis wi ...... Group and Mycoses Study Group.
@nl
P2093
P1476
Treatment of histoplasmosis wi ...... Group and Mycoses Study Group
@en
P2093
C Kauffman
D Bamberger
D McKinsey
D Schneider
J Stansell
K J Shakan
P304
P356
10.1016/S0002-9343(97)00151-4
P407
P577
1997-09-01T00:00:00Z